{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:07:53Z","timestamp":1788908873538,"version":"build-2803163510"},"reference-count":50,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.3724\/abbs.2022157","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T06:04:07Z","timestamp":1675663447000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Secreted phosphoprotein 1 promotes angiogenesis of glioblastoma through upregulating PSMA expression                     via transcription factor HIF-1&amp;alpha;"],"prefix":"10.3724","author":[{"given":"Wenjing","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshuai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/ijms21061932","volume":"21","author":"Vollmann-Zwerenz A","year":"2020","unstructured":"Vollmann-Zwerenz A, Leidgens V, Feliciello G, Klein CA, Hau P. Tumor cell invasion in glioblastoma. Int J Mol Sci, 2020, 21:","journal-title":"Int J Mol Sci"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/ph13110389","volume":"13","author":"Khaddour K","year":"2020","unstructured":"Khaddour K, Johanns TM, Ansstas G. The landscape of novel therapeutics and challenges in glioblastoma multiforme: contemporary state and future directions. Pharmaceuticals, 2020, 13:","journal-title":"Pharmaceuticals"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3171\/2018.12.JNS182926","volume":"132","author":"Li C","year":"2020","unstructured":"Li C, Wang S, Yan JL, Torheim T, Boonzaier NR, Sinha R, Matys T. Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging. J Neurosurg, 2020, 132: 1465-1472.","journal-title":"J Neurosurg"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrn3765","volume":"15","author":"Cuddapah VA","year":"2014","unstructured":"Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci, 2014, 15: 455-465.","journal-title":"Nat Rev Neurosci"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/351908","volume":"2010","author":"Takano S","year":"2010","unstructured":"Takano S, Yamashita T, Ohneda O. Molecular therapeutic targets for glioma angiogenesis. J Oncol, 2010, 2010: 1-11.","journal-title":"J Oncol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom8010001","volume":"8","author":"Stacker SA","year":"2018","unstructured":"Stacker SA, Achen MG. Emerging roles for VEGF-D in human disease. Biomolecules, 2018, 8: 1-7.","journal-title":"Biomolecules"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","volume":"17","author":"Lieu C","year":"2011","unstructured":"Lieu C, Heymach J, Overman M, Tran H, Kopetz S. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res, 2011, 17: 6130-6139.","journal-title":"Clin Cancer Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0002-9440(10)63413-X","volume":"165","author":"Machein MR","year":"2004","unstructured":"Machein MR, Knedla A, Knoth R, Wagner S, Neuschl E, Plate KH. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol, 2004, 165: 1557-1570.","journal-title":"Am J Pathol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","volume":"57","author":"Ahir BK","year":"2020","unstructured":"Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol, 2020, 57: 2461-2478.","journal-title":"Mol Neurobiol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"2106606","DOI":"10.1002\/adma.202106606","volume":"34","author":"Wang Z","year":"2022","unstructured":"Wang Z, Yang Z, Jiang J, Shi Z, Mao Y, Qin N, Tao TH. Silk microneedle patch capable of on\u2010demand multidrug delivery to the brain for glioblastoma treatment. Adv Mater, 2022, 34:","journal-title":"Adv Mater"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jconrel.2021.09.031","volume":"339","author":"Sousa F","year":"2021","unstructured":"Sousa F, Costa-Pereira AI, Cruz A, Ferreira FJ, Gouveia M, Bessa J, Sarmento B. Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass. J Control Release, 2021, 339: 381-390.","journal-title":"J Control Release"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.3390\/ijms21114179","volume":"21","author":"Frisch A","year":"2020","unstructured":"Frisch A, K\u00e4lin S, Monk R, Radke J, Heppner FL, K\u00e4lin RE. Apelin controls angiogenesis-dependent glioblastoma growth. Int J Mol Sci, 2020, 21:","journal-title":"Int J Mol Sci"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"18002","DOI":"10.1038\/s41598-018-36280-9","volume":"8","author":"Parker JJ","year":"2018","unstructured":"Parker JJ, Canoll P, Niswander L, Kleinschmidt-DeMasters BK, Foshay K, Waziri A. Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma. Sci Rep, 2018, 8:","journal-title":"Sci Rep"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"CD008218","DOI":"10.1002\/14651858.CD008218.pub4","volume":"2018","author":"Ameratunga M","year":"2018","unstructured":"Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M. Anti-angiogenic therapy for high-grade glioma. Cochrane Database Systatic Rev, 2018, 2018:","journal-title":"Cochrane Database Systatic Rev"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"598377","DOI":"10.3389\/fcell.2021.598377","volume":"9","author":"Gao Y","year":"2021","unstructured":"Gao Y, Zheng H, Li L, Feng M, Chen X, Hao B, Lv Z. Prostate-specific membrane antigen (PSMA) promotes angiogenesis of glioblastoma through interacting with ITGB4 and regulating NF-\u03baB signaling pathway. Front Cell Dev Biol, 2021, 9:","journal-title":"Front Cell Dev Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/cancers13092244","volume":"13","author":"Hyv\u00e4kk\u00e4 A","year":"2021","unstructured":"Hyv\u00e4kk\u00e4 A, Virtanen V, Kemppainen J, Gr\u00f6nroos TJ, Minn H, Sundvall M. More than meets the eye: scientific rationale behind molecular imaging and therapeutic targeting of prostate-specific membrane antigen (psma) in metastatic prostate cancer and beyond. Cancers, 2021, 13:","journal-title":"Cancers"},{"key":"CITATION17","unstructured":"Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.                                                      Cancer Res                          1999, 59: 3192\u20133198."},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10456-016-9521-x","volume":"19","author":"Conway RE","year":"2016","unstructured":"Conway RE, Rojas C, Alt J, Nov\u00e1kov\u00e1 Z, Richardson SM, Rodrick TC, Fuentes JL. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis, 2016, 19: 487-500.","journal-title":"Angiogenesis"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apm.12195","volume":"122","author":"Wernicke AG","year":"2014","unstructured":"Wernicke AG, Varma S, Greenwood EA, Christos PJ, Chao KS, Liu H, Bander NH. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS, 2014, 122: 482-489.","journal-title":"APMIS"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/pros.24237","volume":"81","author":"Watanabe R","year":"2021","unstructured":"Watanabe R, Maekawa M, Kiyoi T, Kurata M, Miura N, Kikugawa T, Higashiyama S. PSMA\u2010positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state. Prostate, 2021, 81: 1390-1401.","journal-title":"Prostate"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40478-021-01163-0","volume":"9","author":"Wei Q","year":"2021","unstructured":"Wei Q, Singh O, Ekinci C, Gill J, Li M, Mamatjan Y, Karimi S. TNF\u03b1 secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy. Acta Neuropathol Commun, 2021, 9:","journal-title":"Acta Neuropathol Commun"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.3748\/wjg.v20.i30.10440","volume":"20","author":"Wu XL","year":"2014","unstructured":"Wu XL. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World J Gastroenterol, 2014, 20:","journal-title":"World J Gastroenterol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/onc.2013.184","volume":"33","author":"Kale S","year":"2014","unstructured":"Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via \u03b19\u03b21 integrin. Oncogene, 2014, 33: 2295-2306.","journal-title":"Oncogene"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1097\/RLU.0000000000002175","volume":"43","author":"Sasikumar A","year":"2018","unstructured":"Sasikumar A, Kashyap R, Joy A, Charan Patro K, Bhattacharya P, Reddy Pilaka VK, Oommen KE. Utility of 68Ga-PSMA-11 PET\/CT in imaging of glioma\u2014a pilot study. Clin Nucl Med, 2018, 43: e304-e309.","journal-title":"Clin Nucl Med"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2867-14-26","volume":"14","author":"Nomura N","year":"2014","unstructured":"Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, Piccioni D. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int, 2014, 14:","journal-title":"Cancer Cell Int"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11060-018-2825-5","volume":"138","author":"Matsuda M","year":"2018","unstructured":"Matsuda M, Ishikawa E, Yamamoto T, Hatano K, Joraku A, Iizumi Y, Masuda Y. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody. J Neurooncol, 2018, 138: 581-589.","journal-title":"J Neurooncol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00259-018-3934-2","volume":"45","author":"Kunikowska J","year":"2018","unstructured":"Kunikowska J, Bartosz K, Leszek K. Glioblastoma multiforme: another potential application for 68Ga-PSMA PET\/CT as a guide for targeted therapy. Eur J Nucl Med Mol Imag, 2018, 45: 886-887.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/geno.2000.6446","volume":"73","author":"Watt F","year":"2001","unstructured":"Watt F, Martorana A, Brookes DE, Ho T, Kingsley E, O\u2032Keefe DS, Russell PJ. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics, 2001, 73: 243-254.","journal-title":"Genomics"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/pros.23743","volume":"79","author":"Peng W","year":"2019","unstructured":"Peng W, Guo L, Tang R, Liu X, Jin R, Dong JT, Xing CG. Sox7 negatively regulates prostate\u2010specific membrane antigen (PSMA) expression through PSMA\u2010enhancer. Prostate, 2019, 79: 370-378.","journal-title":"Prostate"},{"key":"CITATION30","doi-asserted-by":"crossref","unstructured":"Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling.                                                      J Cell Biochem                          1998, 102: 92\u2013102.","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<92::AID-JCB13>3.0.CO;2-A"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.actatropica.2006.05.001","volume":"98","author":"Maeno Y","year":"2006","unstructured":"Maeno Y, Nakazawa S, Dao LD, Van Tuan N, Giang ND, Van Hanh T, Taniguchi K. Osteopontin is involved in Th1-mediated immunity against Plasmodium falciparum infection in a holoendemic malaria region in Vietnam. Acta Tropica, 2006, 98: 305-310.","journal-title":"Acta Tropica"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2004-08-3228","volume":"106","author":"Renkl AC","year":"2005","unstructured":"Renkl AC, Wussler J, Ahrens T, Thoma K\u0308, Kon S, Uede T, Martin SF. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood, 2005, 106: 946-955.","journal-title":"Blood"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41374-019-0326-6","volume":"100","author":"Krstic M","year":"2020","unstructured":"Krstic M, Hassan HM, Kolendowski B, Hague MN, Anborgh PH, Postenka CO, Torchia J. Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis. Lab Invest, 2020, 100: 400-413.","journal-title":"Lab Invest"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s42003-020-01333-1","volume":"3","author":"Raineri D","year":"2020","unstructured":"Raineri D, Dianzani C, Cappellano G, Maione F, Baldanzi G, Iacobucci I, Clemente N. Osteopontin binds ICOSL promoting tumor metastasis. Commun Biol, 2020, 3:","journal-title":"Commun Biol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/carcin\/bgz190","volume":"41","author":"Giopanou I","year":"2020","unstructured":"Giopanou I, Kanellakis NI, Giannou AD, Lilis I, Marazioti A, Spella M, Papaleonidopoulos V. Osteopontin drives KRAS-mutant lung adenocarcinoma. Carcinogenesis, 2020, 41: 1134-1144.","journal-title":"Carcinogenesis"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1054\/bjoc.2000.1150","volume":"82","author":"Takano S","year":"2000","unstructured":"Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer, 2000, 82: 1967-1973.","journal-title":"Br J Cancer"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/neuonc\/nox165","volume":"20","author":"Szulzewsky F","year":"2018","unstructured":"Szulzewsky F, Schwendinger N, G\u00fcneykaya D, Cimino PJ, Hambardzumyan D, Synowitz M, Holland EC. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment. Neuro-Oncology, 2018, 20: 355-366.","journal-title":"Neuro-Oncology"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.62.12.18","volume":"62","author":"Lou H","year":"2021","unstructured":"Lou H, Wu LQ, Wang H, Wei RL, Cheng JW. The potential role of osteopontin in the pathogenesis of Graves\u2019 ophthalmopathy. Invest Ophthalmol Vis Sci, 2021, 62:","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40659-020-00307-1","volume":"53","author":"Liu M","year":"2020","unstructured":"Liu M, Xu W, Su M, Fan P. REC8 suppresses tumor angiogenesis by inhibition of NF-\u03baB-mediated vascular endothelial growth factor expression in gastric cancer cells. Biol Res, 2020, 53:","journal-title":"Biol Res"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fgene.2020.00547","volume":"11","author":"Guo Z","year":"2020","unstructured":"Guo Z, Huang J, Wang Y, Liu XP, Li W, Yao J, Li S. Analysis of expression and its clinical significance of the secreted phosphoprotein 1 in lung adenocarcinoma. Front Genet, 2020, 11:","journal-title":"Front Genet"},{"key":"CITATION41","unstructured":"Wang J, Hao F, Fei X, Chen Y. SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c.                                                      Am J Transl Res                          2019, 11: 6924\u20136937."},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"646390","DOI":"10.3389\/fcell.2021.646390","volume":"9","author":"Tang H","year":"2021","unstructured":"Tang H, Chen J, Han X, Feng Y, Wang F. Upregulation of SPP1 is a marker for poor lung cancer prognosis and contributes to cancer progression and cisplatin resistance. Front Cell Dev Biol, 2021, 9:","journal-title":"Front Cell Dev Biol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5806602","volume":"2021","author":"Pang X","year":"2021","unstructured":"Pang X, Zhang J, He X, Gu Y, Qian BZ, Xie R, Yu W. SPP1 promotes enzalutamide resistance and epithelial-mesenchymal-transition activation in castration-resistant prostate cancer via PI3K\/AKT and ERK1\/2 pathways. Oxid Med Cell Longev, 2021, 2021: 1-15.","journal-title":"Oxid Med Cell Longev"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"565383","DOI":"10.3389\/fmolb.2020.565383","volume":"7","author":"Wei T","year":"2020","unstructured":"Wei T, Bi G, Bian Y, Ruan S, Yuan G, Xie H, Zhao M. The significance of secreted phosphoprotein 1 in multiple human cancers. Front Mol Biosci, 2020, 7:","journal-title":"Front Mol Biosci"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.7150\/thno.47432","volume":"10","author":"Deng G","year":"2020","unstructured":"Deng G, Zeng F, Su J, Zhao S, Hu R, Zhu W, Hu S. BET inhibitor suppresses melanoma progression                         via the noncanonical NF-\u03baB\/SPP1 pathway. Theranostics, 2020, 10: 11428-11443.","journal-title":"Theranostics"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9098215","volume":"2018","author":"Chiu TJ","year":"2018","unstructured":"Chiu TJ, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH. Osteopontin expression is associated with the poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Biomed Res Int, 2018, 2018: 1-9.","journal-title":"Biomed Res Int"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"e775","DOI":"10.1016\/j.wneu.2019.06.219","volume":"130","author":"Chen J","year":"2019","unstructured":"Chen J, Hou C, Zheng Z, Lin H, Lv G, Zhou D. Identification of Secreted phosphoprotein 1 (SPP1) as a prognostic factor in lower-grade gliomas. World Neurosurg, 2019, 130: e775-e785.","journal-title":"World Neurosurg"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"eaau7518","DOI":"10.1126\/sciadv.aau7518","volume":"5","author":"Blatchley MR","year":"2019","unstructured":"Blatchley MR, Hall F, Wang S, Pruitt HC, Gerecht S. Hypoxia and matrix viscoelasticity sequentially regulate endothelial progenitor cluster-based vasculogenesis. Sci Adv, 2019, 5:","journal-title":"Sci Adv"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"Masoud GN","year":"2015","unstructured":"Masoud GN, Li W. HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sin B, 2015, 5: 378-389.","journal-title":"Acta Pharmaceutica Sin B"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1074\/jbc.RA119.012131","volume":"295","author":"Fu C","year":"2020","unstructured":"Fu C, An N, Liu J, A. J, Zhang B, Liu M, Zhang Z. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1\u03b1 in liver cancer cells. J Biol Chem, 2020, 295: 7060-7074.","journal-title":"J Biol Chem"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CE854C85748F49F99F33EF804E48D6F9","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CE854C85748F49F99F33EF804E48D6F9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T06:04:11Z","timestamp":1675663451000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":50,"URL":"https:\/\/doi.org\/10.3724\/abbs.2022157","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}